Yiting Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yiting Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bibi Yazgulyyeva
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China
2 shared publications - Bo Xiao
Department of Neurology Xiangya Hospital, Central South University Changsha China
2 shared publications - Dandan Sheng
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China
2 shared publications - Jing Liu
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China
2 shared publications - Weiping Liu
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China
2 shared publications - Xinru Li
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China
2 shared publications
Latest Publications
- 10 July 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (4) , 212
Role of the miR-340-5p/IRF1/USP18 Axis in Neuroinflammation Associated with Epilepsy
Epilepsy is a prevalent neurological disorder, in which maladaptive neuroinflammation critically contributes to epileptogenesis. In this study, we identified a previously unrecognized signaling axis that regulates inflammatory responses and inflammatory cell death in experimental epilepsy. Integrated bioinformatic analyses of the GSE73878 and GSE18740 datasets, together with transcription factor and microRNA prediction databases, highlighted USP18 and its upstream regulators as key candidates. Functional and mechanistic validations were performed using lipopolysaccharide-stimulated BV2 microglia and pentylenetetrazole-induced mouse seizure models. Seizure severity and epileptic phenotypes were confirmed using the Racine scale assessments and EEG recordings. USP18 was markedly upregulated under epileptic conditions accompanied by increased pro-inflammatory cytokine release, apoptosis, and pyroptosis. Silencing USP18 attenuated neuroinflammation and reduced seizure severity. Mechanistically, interferon regulatory factor 1 (IRF1) was identified as a direct transcriptional activator of USP18, whereas miR-340-5p suppressed USP18 expression by targeting IRF1, thereby mitigating inflammatory signaling and neuronal injury. Collectively, these findings reveal a novel regulatory pathway linking microRNA-mediated control, interferon-responsive transcription, and inflammatory effector mechanisms in epilepsy, and suggest that targeting the miR-340-5p/IRF1/USP18 axis may represent a promising disease-modifying therapeutic strategy.
- 10 July 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (4) , 212
Role of the miR-340-5p/IRF1/USP18 Axis in Neuroinflammation Associated with Epilepsy
Epilepsy is a prevalent neurological disorder, in which maladaptive neuroinflammation critically contributes to epileptogenesis. In this study, we identified a previously unrecognized signaling axis that regulates inflammatory responses and inflammatory cell death in experimental epilepsy. Integrated bioinformatic analyses of the GSE73878 and GSE18740 datasets, together with transcription factor and microRNA prediction databases, highlighted USP18 and its upstream regulators as key candidates. Functional and mechanistic validations were performed using lipopolysaccharide-stimulated BV2 microglia and pentylenetetrazole-induced mouse seizure models. Seizure severity and epileptic phenotypes were confirmed using the Racine scale assessments and EEG recordings. USP18 was markedly upregulated under epileptic conditions accompanied by increased pro-inflammatory cytokine release, apoptosis, and pyroptosis. Silencing USP18 attenuated neuroinflammation and reduced seizure severity. Mechanistically, interferon regulatory factor 1 (IRF1) was identified as a direct transcriptional activator of USP18, whereas miR-340-5p suppressed USP18 expression by targeting IRF1, thereby mitigating inflammatory signaling and neuronal injury. Collectively, these findings reveal a novel regulatory pathway linking microRNA-mediated control, interferon-responsive transcription, and inflammatory effector mechanisms in epilepsy, and suggest that targeting the miR-340-5p/IRF1/USP18 axis may represent a promising disease-modifying therapeutic strategy.
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 761
Exploratory Analysis of Autophagy-related Genes and Immune Infiltration in Human Hippocampal Tissue of Temporal Lobe Epilepsy
Epilepsy results from an imbalance between excitation and inhibition of neurons, with 30–40% of cases being temporal lobe epilepsy (TLE). This study aimed to prioritize autophagy-related genes and explore their potential links to immune features in human hippocampal tissue of TLE. Two hippocampal transcriptomic datasets (GSE202101 and GSE11882) were analyzed to identify autophagy-related differentially expressed genes (ARDEGs). Functional enrichment, regulatory network, and immune cell infiltration analyses were performed. LASSO regression and consensus clustering were applied. Exploratory assessment of the candidate gene signature was conducted in an independent dataset (GSE256068). Immunohistochemistry (IHC) on clinical specimens assessed protein expression of candidate signature genes. An eight‑gene candidate signature was derived, and subsequent PPI network analysis revealed LARP1, EIF4G1, and TSC2 as hub genes among them. Exploratory assessment in an independent dataset partially replicated the expression patterns of PYCARD, EIF4G1, and TSC2, whereas LARP1 showed an opposite expression trend; overall model performance remained modest. Increased activated mast cells were observed in TLE samples, while higher levels of plasma cells, CD8⁺ T cells, and regulatory T cells were observed in controls. Two exploratory clusters with distinct immune correlation patterns were identified. IHC showed upregulation of ABL1, TSC2, and SPP1 protein levels in TLE tissue. This study prioritizes a set of autophagy-related candidate genes in human hippocampal tissue and provides an exploratory framework linking them to local immune features in TLE. Further validation in larger independent cohorts is warranted before any clinical interpretation.
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 761
Exploratory Analysis of Autophagy-related Genes and Immune Infiltration in Human Hippocampal Tissue of Temporal Lobe Epilepsy
Epilepsy results from an imbalance between excitation and inhibition of neurons, with 30–40% of cases being temporal lobe epilepsy (TLE). This study aimed to prioritize autophagy-related genes and explore their potential links to immune features in human hippocampal tissue of TLE. Two hippocampal transcriptomic datasets (GSE202101 and GSE11882) were analyzed to identify autophagy-related differentially expressed genes (ARDEGs). Functional enrichment, regulatory network, and immune cell infiltration analyses were performed. LASSO regression and consensus clustering were applied. Exploratory assessment of the candidate gene signature was conducted in an independent dataset (GSE256068). Immunohistochemistry (IHC) on clinical specimens assessed protein expression of candidate signature genes. An eight‑gene candidate signature was derived, and subsequent PPI network analysis revealed LARP1, EIF4G1, and TSC2 as hub genes among them. Exploratory assessment in an independent dataset partially replicated the expression patterns of PYCARD, EIF4G1, and TSC2, whereas LARP1 showed an opposite expression trend; overall model performance remained modest. Increased activated mast cells were observed in TLE samples, while higher levels of plasma cells, CD8⁺ T cells, and regulatory T cells were observed in controls. Two exploratory clusters with distinct immune correlation patterns were identified. IHC showed upregulation of ABL1, TSC2, and SPP1 protein levels in TLE tissue. This study prioritizes a set of autophagy-related candidate genes in human hippocampal tissue and provides an exploratory framework linking them to local immune features in TLE. Further validation in larger independent cohorts is warranted before any clinical interpretation.